Davis Polk advised the placement agents in connection with a private placement of shares of common stock of Applied Therapeutics, Inc. The aggregate proceeds of the private placement…
Davis Polk advised the joint book-running managers in connection with an offering by Flex Ltd. of $200 million aggregate principal amount of its 4.875% notes due 2029. The notes will form a…
Davis Polk advised MSCI Inc. in connection with a Rule 144A/Regulation S offering of $500 million aggregate principal amount of its 4.000% senior notes due 2029. The notes are guaranteed by…
Davis Polk advised the initial purchasers in connection with a Regulation S offering by Zhenro Properties Group Limited of $300 million 9.15% senior notes due 2023.
Zhenro Properties Group…
Davis Polk advised Clarivate Analytics plc in connection with the refinancing of its existing credit facility and unsecured senior notes pursuant to which its indirect wholly owned…
Davis Polk advised Charles River Laboratories International, Inc. in connection with its Rule 144A/Regulation S offering of $500 million aggregate principal amount of 4.250% senior notes…
Davis Polk advised the sole dealer manager in connection with a cash tender offer by Genesis Purchaser, LLC, an indirect subsidiary of NextEra Energy Partners, LP, for any and all of…
Davis Polk advised the initial purchasers in connection with the offering by Promigas S.A. E.S.P. and its subsidiary Gases del Pacífico S.A.C., as co-issuers, of $400 million aggregate…
Davis Polk advised the dealer managers in connection with a cash tender offer by Spectrum Brands, Inc. for any and all of its 6.250% senior notes due 2022, which were paid for with the…
Davis Polk advised the initial purchasers in connection with a debut Regulation S offering by Zensun Enterprises Limited of $220 million 12.8% senior notes due 2021. The notes are…